| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.081 | 0.08 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.09 |